Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Development and characterization of IRAK-4 inhibitors

Sep. 30, 2019

Inflazome begins first-in-human study of IZD-334 for CAPS

Sep. 27, 2019

Positive topline results presented from phase II STAR study of tolperisone

Sep. 25, 2019

Phase III PREVENT trial of Cosentyx in nr-axSpA meets 16-week primary endpoint

Sep. 17, 2019

DSMC recommends continuation of U.S. study of IDCT for degenerative disc disease

Sep. 17, 2019

BoNTANA Therapies describes nucleic acids encoding botulinum neurotoxins

Sep. 13, 2019

Genentech describes lead small-molecule IRAK-4 inhibitors

Sep. 9, 2019

Phase III TULIP 2 trial of anifrolumab in SLE meets primary endpoint

Aug. 29, 2019

For proinflammatory antibody, too much of a bad thing is a good thing

Aug. 29, 2019

Bristol-Myers Squibb presents discovery of lupus candidate BMS-615

Aug. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...